SEARCH

SEARCH BY CITATION

References

  • Ando, H., Itoh, A., Mishima, Y., and Ichihashi, M. (1995). Correlation between the number of melanosomes, tyrosinase mRNA levels, and tyrosinase activity in cultured murine melanoma cells in response to various melanogenesis regulatory agents. J. Cell. Physiol. 163, 608614.
  • Asarch, A., Barak, O., Loo, D.S., and Gottlieb, A.B. (2008). Th17 cells: a new therapeutic target in inflammatory dermatoses. J. Dermatolog. Treat. 19, 318326.
  • Baharav, E., Merimski, O., Shoenfeld, Y., Zigelman, R., Gilbrud, B., Yecheskel, G., Youinou, P., and Fishman, P. (1996). Tyrosinase as an autoantigen in patients with vitiligo. Clin. Exp. Immunol. 105, 8488.
  • Basak, P.Y., Adiloglu, A.K., Ceyhan, A.M., Tas, T., and Akkaya, V.B. (2009). The role of helper and regulatory T cells in the pathogenesis of vitiligo. J. Am. Acad. Dermatol. 60, 256260.
  • Bassiouny, D.A., and Shaker, O. (2011). Role of interleukin-17 in the pathogenesis of vitiligo. Clin. Exp. Dermatol. 36, 292297.
  • Caixia, T., Hongwen, F., and Xiran, L. (1999). Levels of soluble interleukin-2 receptor in the sera and skin tissue fluids of patients with vitiligo. J. Dermatol. Sci. 21, 5962.
  • Chalraborty, A., and Pawelek, J. (1993). MSH receptors in immortalized human epidermal keratinocytes: a potential mechanism for coordinate regulation of the epidermal-melanin unit. J. Cell. Physiol. 157, 344350.
  • Cui, J., Harning, R., Henn, M., and Bystryn, J.C. (1992). Identification of pigment cell antigens defined by vitiligo antibodies. J. Invest. Dermatol. 98, 162165.
  • Daneshpazhooh, M., Mostofizadeh, G.M., Behjati, J., Akhyani, M., and Robati, R.M. (2006). Anti-thyroid peroxidase antibody and vitiligo: a controlled study. BMC Dermatol. 6, 3.
  • Diveu, C., Mcgeachy, M.J., and Cua, D.J. (2008). Cytokines that regulate autoimmunity. Curr. Opin. Immunol. 20, 663668.
  • Englaro, W., Bahadoran, P., Bertolotto, C., Busca, R., Derijard, B., Livolsi, A., Peyron, J.F., Ortonne, J.P., and Ballotti, R. (1999). Tumor necrosis factor alpha-mediated inhibition of melanogenesis is dependent on nuclear factor kappa B activation. Oncogene 18, 15531559.
  • Fitch, E.L., Rizzo, H.L., Kurtz, S.E., Wegmann, K.W., Gao, W., Benson, J.M., Hinrichs, D.J., and Blauvelt, A. (2009). Inflammatory skin disease in K5.hTGF-beta1 transgenic mice is not dependent on the IL-23/Th17 inflammatory pathway. J. Invest. Dermatol. 129, 24432450.
  • Gould, I.M., Gray, R.S., Urbaniak, S.J., Elton, R.A., and Duncan, L.J. (1985). Vitiligo in diabetes mellitus. Br. J. Dermatol. 113, 153155.
  • Hegedus, L., Heidenheim, M., Gervil, M., Hjalgrim, H., and Hoier-Madsen, M. (1994). High frequency of thyroid dysfunction in patients with vitiligo. Acta Derm. Venereol. 74, 120123.
  • Howitz, J., Brodthagen, H., Schwartz, M., and Thomsen, K. (1977). Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark. Arch. Dermatol. 113, 4752.
  • Infante-Duarte, C., Horton, H.F., Byrne, M.C., and Kamradt, T. (2000). Microbial lipopeptides induce the production of IL-17 in Th cells. J. Immunol. 165, 61076115.
  • Jin, Y., Mailloux, C.M., Gowan, K., Riccardi, S.L., Laberge, G., Bennett, D.C., Fain, P.R., and Spritz, R.A. (2007). NALP1 in vitiligo-associated multiple autoimmune disease. N. Engl. J. Med. 356, 12161225.
  • Jin, Y., Riccardi, S.L., Gowan, K., Fain, P.R., and Spritz, R.A. (2010). Fine-mapping of vitiligo susceptibility loci on chromosomes 7 and 9 and interactions with NLRP1 (NALP1). J. Invest. Dermatol. 130, 774783.
  • Kamaraju, A.K., Bertolotto, C., Chebath, J., and Revel, M. (2002). Pax3 down-regulation and shut-off of melanogenesis in melanoma B16/F10.9 by interleukin-6 receptor signaling. J. Biol. Chem. 277, 1513215141.
  • Kholmanskikh, O., Van Baren, N., Brasseur, F., Ottaviani, S., Vanacker, J., Arts, N., Van Der Bruggen, P., Coulie, P., and De Plaen, E. (2010). Interleukins 1alpha and 1beta secreted by some melanoma cell lines strongly reduce expression of MITF-M and melanocyte differentiation antigens. Int. J. Cancer 127, 16251636.
  • Kingo, K., Aunin, E., Karelson, M., Ratsep, R., Silm, H., Vasar, E., and Koks, S. (2008). Expressional changes in the intracellular melanogenesis pathways and their possible role in the pathogenesis of vitiligo. J. Dermatol. Sci. 52, 3946.
  • Kolls, J.K., and Linden, A. (2004). Interleukin-17 family members and inflammation. Immunity 21, 467476.
  • Lang, K.S., Caroli, C.C., Muhm, A., Wernet, D., Moris, A., Schittek, B., Knauss-Scherwitz, E., Stevanovic, S., Rammensee, H.G., and Garbe, C. (2001). HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1. J. Invest. Dermatol. 116, 891897.
  • Levy, C., Khaled, M., and Fisher, D.E. (2006). MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol. Med. 12, 406414.
  • Liang, S.C., Tan, X.Y., Luxenberg, D.P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., and Fouser, L.A. (2006). Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203, 22712279.
  • Mihailova, D., Grigorova, R., Vassileva, B., Mladenova, G., Ivanova, N., Stephanov, S., Lissitchky, K., and Dimova, E. (1999). Autoimmune thyroid disorders in juvenile chronic arthritis and systemic lupus erythematosus. Adv. Exp. Med. Biol. 455, 5560.
  • Mishima, Y., Kawasaki, H., and Pinkus, H. (1972). Dendritic cell dynamics in progressive depigmentations. Distinctive cytokinetics of -dendritic cells revealed by electron microscopy. Arch. Dermatol. Forsch. 243, 6787.
  • Moretti, S., Spallanzani, A., Amato, L., Hautmann, G., Gallerani, I., Fabiani, M., and Fabbri, P. (2002). New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions. Pigment Cell Res. 15, 8792.
  • Moretti, S., Fabbri, P., Baroni, G., Berti, S., Bani, D., Berti, E., Nassini, R., Lotti, T., and Massi, D. (2009). Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis. Histol. Histopathol. 24, 849857.
  • Norris, D.A., Horikawa, T., and Morelli, J.G. (1994). Melanocyte destruction and repopulation in vitiligo. Pigment Cell Res. 7, 193203.
  • Ogg, G.S., Rod Dunbar, P., Romero, P., Chen, J.L., and Cerundolo, V. (1998). High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo. J. Exp. Med. 188, 12031208.
  • Okamoto, T., Irie, R.F., Fujii, S., Huang, S.K., Nizze, A.J., Morton, D.L., and Hoon, D.S. (1998). Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy. J. Invest. Dermatol. 111, 10341039.
  • Ongenae, K., Van Geel, N., and Naeyaert, J.M. (2003). Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res. 16, 90100.
  • Ratsep, R., Kingo, K., Karelson, M., Reimann, E., Raud, K., Silm, H., Vasar, E., and Koks, S. (2008). Gene expression study of IL10 family genes in vitiligo skin biopsies, peripheral blood mononuclear cells and sera. Br. J. Dermatol. 159, 12751281.
  • Ruiz-Arguelles, A., Brito, G.J., Reyes-Izquierdo, P., Perez-Romano, B., and Sanchez-Sosa, S. (2007). Apoptosis of melanocytes in vitiligo results from antibody penetration. J. Autoimmun. 29, 281286.
  • Schallreuter, K.U., Lemke, R., Brandt, O., Schwartz, R., Westhofen, M., Montz, R., and Berger, J. (1994a). Vitiligo and other diseases: coexistence or true association? Hamburg study on 321 patients. Dermatology 188, 269275.
  • Schallreuter, K.U., Wood, J.M., Pittelkow, M.R., Gutlich, M., Lemke, K.R., Rodl, W., Swanson, N.N., Hitzemann, K., and Ziegler, I. (1994b). Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin. Science 263, 14441446.
  • Swope, V.B., Sauder, D.N., Mckenzie, R.C., Sramkoski, R.M., Krug, K.A., Babcock, G.F., Nordlund, J.J., and Abdel-Malek, Z.A. (1994). Synthesis of interleukin-1 alpha and beta by normal human melanocytes. J. Invest. Dermatol. 102, 749753.
  • Virador, V.M., Kobayashi, N., Matsunaga, J., and Hearing, V.J. (1999). A standardized protocol for assessing regulators of pigmentation. Anal. Biochem. 270, 207219.
  • Wang, C.Q., Cruz-Inigo, A.E., Fuentes-Duculan, J., Moussai, D., Gulati, N., Sullivan-Whalen, M., Gilleaudeau, P., Cohen, J.A., and Krueger, J.G. (2011). Th17 cells and activated dendritic cells are increased in vitiligo lesions. PLoS ONE 6, e18907.
  • Wilson, N.J., Boniface, K., Chan, J.R. et al. (2007). Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 8, 950957.